Head to Head Review: Ambu A/S (AMBBY) and Its Peers

Ambu A/S (OTCMKTS:AMBBYGet Free Report) is one of 664 public companies in the “Holding & other investment offices” industry, but how does it compare to its competitors? We will compare Ambu A/S to related companies based on the strength of its institutional ownership, analyst recommendations, earnings, valuation, profitability, risk and dividends.

Earnings and Valuation

This table compares Ambu A/S and its competitors revenue, earnings per share and valuation.

Gross Revenue Net Income Price/Earnings Ratio
Ambu A/S $684.73 million $24.09 million 96.25
Ambu A/S Competitors $1.12 billion $84.15 million 44.37

Ambu A/S’s competitors have higher revenue and earnings than Ambu A/S. Ambu A/S is trading at a higher price-to-earnings ratio than its competitors, indicating that it is currently more expensive than other companies in its industry.

Institutional and Insider Ownership

54.2% of shares of all “Holding & other investment offices” companies are held by institutional investors. 25.4% of shares of all “Holding & other investment offices” companies are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Analyst Recommendations

This is a summary of current ratings and target prices for Ambu A/S and its competitors, as provided by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Ambu A/S 0 0 1 0 3.00
Ambu A/S Competitors 126 559 858 14 2.49

As a group, “Holding & other investment offices” companies have a potential upside of 74.07%. Given Ambu A/S’s competitors higher possible upside, analysts plainly believe Ambu A/S has less favorable growth aspects than its competitors.

Profitability

This table compares Ambu A/S and its competitors’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Ambu A/S 7.23% 6.80% 5.32%
Ambu A/S Competitors -24.64% -46.27% -1.23%

About Ambu A/S

(Get Free Report)

Ambu A/S develops, produces, and sells medical devices to hospitals, clinics, and rescue services worldwide. The company offers anaesthesia, and patient monitoring and diagnostics products. The company also offers endoscopy products, such as bronchoscopes, rhinolaryngoscopes, duodenoscopes, cystoscopes, and display units; and neurology products, including EEG and EMG electrodes, EMG guided injections, and intraoperative monitoring products. It also provides cardiology products consisting of airway management and anaesthesia products, such as bronchoscopes, video laryngoscopes, double and single lumen tubes, endobronchial blockers, laryngeal and face masks, breathing bags, and resuscitators. In addition, the company offers extrication collars, CPR breathing barriers, video laryngoscopes, and training manikins. The company was founded in 1937 and is headquartered in Ballerup, Denmark.

Receive News & Ratings for Ambu A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ambu A/S and related companies with MarketBeat.com's FREE daily email newsletter.